regulatory loopholes
05/14/2018
/
By Tracey Watson
A form of vitamin B6, pyridoxamine, could be back on the market after being unavailable for years to protect its potential use in pharmaceuticals
Did you know that in the United States, if a pharmaceutical company can prove to the U.S. Food and Drug Administration (FDA) that an ingredient was not marketed as a dietary supplement prior to 1994, and that it was first investigated by a drug company, that said ingredient can be placed on a list that […]
« Return Home
1 of 1
Popular Articles
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy